Powered by

What were the highs and lows of 2016? We look at key trends globally across ECM, DCM, Loans, M&A, and IB Strategy, according to Dealogic figures. For more information or a full copy of our Full Year 2016 Reviews, please reach out to our teams below.

Global ECM Highlights

Global ECM volume of $724.2bn in 2016 marked the lowest annual total since 2012, with volume dropping 21% from 2015 ($913.1bn). IPOs ($135.6bn) were at the lowest level since 2012 ($124.3bn) and down 30% year-on-year.

Global DCM Highlights

Global DCM issuance climbed 9% to $6.69tr in 2016, compared to 2015 volume of $6.13tr, and just shy of the record high of $6.61tr in 2006. It was also a record-breaking year for internationally marketed DCM ($4.23tr), which surpassed the previous high set in 2014 ($4.15tr), and was up 6% compared to 2015. Green bond issuance doubled from the previous record in 2015, with $78.9bn via 168 deals.

Global Loans Highlights

Global syndicated loan volume totaled $4.29tr in 2016, the lowest level since 2012 ($3.48tr) and down 5% on $4.51tr borrowed in 2015. Acquisition-related loan volume of $1.11tr was up 4% year-on-year, the third consecutive year-on-year increase since 2013 ($687.8bn). Technology topped the global loan sector ranking with a 12% market share, followed by Utility & Energy (10%) and Telecom (10%), respectively.

Global M&A Highlights

After three consecutive year-on-year increases, 2016 global M&A of $3.84tr dropped from the 2015 annual record high of $4.66tr. While volume fell 18% year-on-year, M&A revenue was down only 2%. Cross-border M&A was down 3% globally year-on-year, but China outbound volume hit a record high ($225.4bn) as did US inbound M&A ($486.3bn). 4Q global M&A ($1.27tr) hit the $1tr mark in the first week of December, the third largest quarter on record following 2Q 2007 ($1.51tr) and 4Q 2015 ($1.39tr).

Global Investment Banking Strategy Highlights

2016 started at the slowest pace in six years for global investment banking (IB), with 1Q revenue of $16.3bn down 18% to the lowest 1Q total since 2010 ($15.4bn). This decline eased through the year, with 3Q ($19.8bn) recovering to the biggest quarter since 2Q 2015 ($21.8bn) and 4Q 2016 revenue of $18.1bn increasing from $17.8bn in 4Q 2015.

 

For more information or a full copy of our Full Year 2016 Reviews, please reach out to our teams below:

Press Queries

Client Queries

More in ECM:

  1. Report

    73% of 2016 US IPOs trading above their offer price

    December 2016

  2. Video

    How did US ECM activity fare in an election month?

    December 2016

  3. Video

    The election is over, what now?

    November 2016

  4. Report

    Samsung BioLogics completes world's largest healthcare IPO in 2 years, using Dealogic

    October 2016